56172-71-5

Basic information

• Product Name: CYCLOPROPANECARBOXYLIC ACID, 1-ACETYL-
• Synonyms: CYCLOPROPANECARBOXYLIC ACID, 1-ACETYL-;1-acetylcyclopropanecarboxylic acid;1-Acetylcyclopropane-1-carboxylic acid;1-Acetyl-1-carboxycyclopropane, 1-Ethanoylcyclopropane-1-carboxylic acid
• CAS NO: 56172-71-5
• Molecular Formula: C₆H₈O₃
• Molecular Weight: 128.13
• Mol File: 56172-71-5.mol
• Article Data: 9

Chemical Properties

• Boiling Point: 263.072°C at 760 mmHg
• Flash Point: 127.155°C
• Appearance: /
• Density: 1.346g/cm³
• Vapor Pressure: 0.003mmHg at 25°C
• Refractive Index: 1.523
• Storage Temp.: 2-8°C
• CAS DataBase Reference: CYCLOPROPANECARBOXYLIC ACID, 1-ACETYL-(CAS DataBase Reference)
• NIST Chemistry Reference: CYCLOPROPANECARBOXYLIC ACID, 1-ACETYL-(56172-71-5)
• EPA Substance Registry System: CYCLOPROPANECARBOXYLIC ACID, 1-ACETYL-(56172-71-5)

Safety Data

• Hazardous Substances Data: 56172-71-5(Hazardous Substances Data)

Usage

Synthesis Reference(s)

The Journal of Organic Chemistry, 40, p. 2969, 1975 DOI: 10.1021/jo00908a030

InChI:InChI=1/C6H8O3/c1-4(7)6(2-3-6)5(8)9/h2-3H2,1H3,(H,8,9)

Upstream product

• 141-97-9 ethyl acetoacetate 
• 106-93-4 ethylene dibromide 
• 32933-03-2 ethyl 1-acetylcyclopropanecarboxylate 
• 38806-09-6 1-acetylcyclopropanecarboxylic acid methyl ester 
• 1694-31-1 tert-butyl acetoacetate 

Downstream Products

• 1318756-83-0 1-acetyl-N-[2-(3-chloro-5-fluorobenzyl)-4-methyl-1,3-thiazol-5-yl]cyclopropanecarboxamide 
• 133374-52-4 endo-spiro<1-methyl-3-phenyl-2,7-dioxabicyclo<2.2.1>heptan-5-one-6,1'-cyclopropane> 
• 133374-52-4 exo-spiro<1-methyl-3-phenyl-2,7-dioxabicyclo<2.2.1>heptan-5-one-6,1'-cyclopropane> 
• 82769-90-2 (1'RS,2'RS,3'SR,4'SR,6'RS)-N,N-dimethyl-1-<1-(2,2-dimethyl-1,1-diazanediyl)-2-(2',3'-dihydroxy-2',4'-dimethyl-6'-(phenylsulfonyl)cyclohexyl)ethyl>cyclopropanecarboxamide 2',3'-acetonide 
• 28282-65-7 spiro<5-hydroxy-2,2,5,7-tetramethyl-5,6-dihydro-2H-inden-1,4-dione-6,1'-cyclopropane> 
• 129321-58-0 (R)-N-(1-phenylethyl)-1-<2-bromo-1,1-(ethylenedioxy)ethyl>-1-cyclopropanecarboxamide 
• 152719-39-6 4,7-dioxo-5-<1(R)-phenylethyl>-5-azaspiro<2.4>heptane 7-ethylene acetal 
• 129321-57-9 (R)-N-(1-phenylethyl)-1-<1,1-(ethylenedioxy)ethyl>-1-cyclopropanecarboxamide 
• 127199-37-5 4,7-dioxo-5-<1(R)-phenylethyl>-5-azaspiro<2.4>heptane 
• 1071-73-4 5-Hydroxy-2-pentanone 
• 124-38-9 carbon dioxide 
• 765-43-5 Cyclopropyl methyl ketone 
• 129321-56-8 (R)-N-(1-phenylethyl)-1-acetyl-1-cyclopropanecarboxamide 
• 82769-88-8 N,N-dimethyl-1-acetylcyclopropanecarboxamide 

Relevant articles and documents

ILLUDIN ANALOGS, USES THEREOF, AND METHODS FOR SYNTHESIZING THE SAME

This invention provides illudin derivatives, intermediates, preparation methods, pharmaceutical compositions and uses thereof. Specific examples include novel synthetic routes to prepare illudin derivatives and an illudin derivative having a positive optical rotation, which has therapeutic value.

COMBINATIONS OF HEPATITIS C VIRUS INHIBITORS

The present disclosure is generally directed to antiviral compounds, and more specifically directed to combinations of compounds which can inhibit the function of the NS5A protein encoded by Hepatitis C virus (HCV), compositions comprising such combinations, and methods for inhibiting the function of the NS5A protein.